CytomX Therapeutics, Inc.

STATE STREET CORP CTMX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

5,140,931

Value ($000)

21,900

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	21,900	0.0%	5,140,931	12/31/2025
2025 Q3	11/14/2025	2,057	0.0%	644,982	9/30/2025
2025 Q2	8/14/2025	1,451	0.0%	639,040	6/30/2025
2025 Q1	5/15/2025	203	0.0%	320,043	3/31/2025
2024 Q4	2/14/2025	330	0.0%	320,043	12/31/2024
2024 Q3	11/14/2024	311	0.0%	263,643	9/30/2024
2024 Q2	8/14/2024	322	0.0%	263,643	6/30/2024
2024 Q1	5/15/2024	583	0.0%	267,476	3/31/2024
2023 Q4	2/14/2024	415	0.0%	267,476	12/31/2023
2023 Q3	11/14/2023	345	0.0%	267,476	9/30/2023
2023 Q2	8/14/2023	460	0.0%	267,476	6/30/2023
2023 Q1	5/15/2023	404	0.0%	267,476	3/31/2023
2022 Q4	5/15/2023	358	0.0%	223,976	12/31/2022
2022 Q3	11/15/2022	325	0.0%	223,976	9/30/2022
2022 Q2	8/15/2022	410	0.0%	223,976	6/30/2022
2022 Q1	5/16/2022	3,200	0.0%	1,198,682	3/31/2022
2021 Q4	2/14/2022	11,862	0.0%	2,739,544	12/31/2021
2021 Q3	11/15/2021	20,548	0.0%	4,036,937	9/30/2021
2021 Q2	8/16/2021	29,223	0.0%	4,616,562	6/30/2021
2021 Q1	7/9/2021	25,964	0.0%	3,358,865	3/31/2021
2020 Q4	2/16/2021	13,431	0.0%	2,050,597	12/31/2020
2020 Q3	11/10/2020	14,293	0.0%	2,149,254	9/30/2020
2020 Q2	8/14/2020	18,290	0.0%	2,195,649	6/30/2020
2020 Q1	6/19/2020	7,570	0.0%	986,948	3/31/2020
2019 Q4	2/6/2020	8,223	0.0%	989,570	12/31/2019